These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 5852638)

  • 21. [Behavior of some hematochemical data and of the most important biological indexes of disease and of phase in subjects affected by pulmonary tuberculosis treated with morphazinamide].
    Caltagirone S
    Minerva Med; 1965 Sep; 56(70):2766-71. PubMed ID: 5322265
    [No Abstract]   [Full Text] [Related]  

  • 22. [On therapeutic effects of morphazinamide, used alone and in association, in recent and chronic pulmonary tuberculosis].
    Pasargiklian M
    Minerva Med; 1965 Sep; 56(71):2855-62. PubMed ID: 5322267
    [No Abstract]   [Full Text] [Related]  

  • 23. [Morphazinamide--clinical tolerance and side effects].
    Lachowicz D; Siekierzyńska A; Styszewska H
    Gruzlica; 1967 May; 35(5):453-63. PubMed ID: 6056260
    [No Abstract]   [Full Text] [Related]  

  • 24. [Problems of post-sanatorial antimycobacterial treatment].
    Corda M
    Minerva Med; 1965 Sep; 56(70):2827-31. PubMed ID: 5852641
    [No Abstract]   [Full Text] [Related]  

  • 25. [Level of blood serum level of uric acid in tuberculous patients treated with morphazinamide].
    Wawrzeńczyk B; Zaruski A
    Gruzlica; 1973 Feb; 41(2):177-80. PubMed ID: 4695789
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of chronic destructive pulmonary tuberculosis by intravenous injections of morphazinamide].
    Utkin VV; Zankisova IG; Polishchuk AK; Krylova NP; Gridneva SM
    Vrach Delo; 1972 Feb; 2():57-8. PubMed ID: 5084744
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical results of piazofoline therapy in pulmonary tuberculosis].
    Deodato M
    Minerva Med; 1965 Sep; 56(71):2897-8. PubMed ID: 5322271
    [No Abstract]   [Full Text] [Related]  

  • 28. [On the therapeutic use of piazofoline in pulmonary tuberculosis].
    Fici V; Fici G
    Minerva Med; 1966 Dec; 57(101):4375-6. PubMed ID: 5958227
    [No Abstract]   [Full Text] [Related]  

  • 29. [Morphazinamide by venous perfusion in therapy of pulmonary tuberculosis].
    Leoncini G; Bolondi O; Costi TF
    Minerva Med; 1965 Sep; 56(71):2910-3. PubMed ID: 5322275
    [No Abstract]   [Full Text] [Related]  

  • 30. [Studies of the therapeutical effects and intolerance levels of morphazinamide in pulmonary tuberculosis].
    Ruiz Benítez G; Bonilla C
    Rev Clin Esp; 1967 Apr; 105(1):28-37. PubMed ID: 5613422
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effects of morphazinamide in monomedicamentous therapy per os and intravenously in pulmonary tuberculosis].
    Sorrentino F; Calagna L
    Minerva Med; 1965 Sep; 56(71):2938-42. PubMed ID: 5322280
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical observations on morphazinamide administered by intravenous perfusion in therapy of pulmonary tuberculosis].
    Lucchesi M; Pallotta G; Fantoli U
    Minerva Med; 1965 Sep; 56(71):2914-8. PubMed ID: 5322276
    [No Abstract]   [Full Text] [Related]  

  • 33. [Morphazinamede alone or associated in treatment of recent and chronic pulmonary tuberculosis. Observations on 48 cases].
    Baroni V; Sidari A
    Minerva Med; 1965 Sep; 56(71):2864-72. PubMed ID: 5322581
    [No Abstract]   [Full Text] [Related]  

  • 34. Association of thymostimulin to antimycobacterial polychemotherapy in pulmonary tuberculosis.
    Zaga V; Tomasini C; Rossi F; Pajello M; Mura P; De Rosa A; Reboa G
    J Chemother; 1989 Jul; 1(4 Suppl):463-4. PubMed ID: 16312486
    [No Abstract]   [Full Text] [Related]  

  • 35. [Control of the time of recovery from pulmonary tuberculosis obtained with specific antimycobacterial therapy alone].
    Leone P
    Lotta Tuberc; 1971; 41(4):579-80. PubMed ID: 5291677
    [No Abstract]   [Full Text] [Related]  

  • 36. [Anatomico-pathological criteria for evaluation of the recovery from pulmonary tuberculosis obtained with antimycobacterial therapy].
    Storniello G
    Lotta Tuberc; 1971; 41(4):527-32. PubMed ID: 5291668
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical experiences with morphazinamide administered in slow venous perfusion in the treatment of pulmonary tuberculosis].
    Censi G; Orlandini GC
    Minerva Med; 1965 Sep; 56(71):2881-92. PubMed ID: 5322269
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pulmonary tuberculosis with resistance to 4 antitubercular drugs].
    Reichlin S; Frei R; Reusser P
    Schweiz Med Wochenschr; 1998 Feb; 128(7):264-7. PubMed ID: 9540152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Possibilities and limitations of multiple chemoantibiotics in treatment of chronic pulmonary tuberculosis].
    Zanotelli F; Perusi O
    G Ital Mal Torace; 1966; 20(6):365-78. PubMed ID: 5997781
    [No Abstract]   [Full Text] [Related]  

  • 40. [Changes in the alveolo-capillary diffusion in patients recovered from pulmonary tuberculosis with specific antimycobacterial therapy].
    Cardaci G; Vittore F; Rognone L
    Lotta Tuberc; 1971; 41(4):624-8. PubMed ID: 5291687
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.